This metabolite deriving from the diet or gut microbiota fermentation has an important influence on fatty acid metabolism and may suppress NAFLD/NASH development by regulating hepatic lipid metabolism and insulin sensitivity via its receptor FFAR2 (free fatty acid receptor 2) in hepatocytes (47). Here, FFAR2 is linked to metabolic dysfunction-associated steatotic liver disease.